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damycin (56.7%), Erythromycin (46.7). In 3 strains production of f3-
lactamase was observed. The species C. propinquum (2), C. pseudodiphther-
iticum (I) presented a particularly high resistance (to 11,8,7 antibiotics). The
highest resistance to the determined antibiotics was presented by strains ofC.
pseudodiphtheritimm i<olatcd from patients with inflammation of nasal
mucosa and pharyngitis.
P:417 - Gram-positive infections - II
[WePf!] Coagulase-negative Staphylococd other than
Staphylococcus saprophyticus as a cause of acute lower urinary
tract infection
C. S. Nice!, K. G. Kerr!·2, F. H. M'Zali' , P. M. Hawkeyl.2
t Leeds General Infirmary: 'Dept. ofMicrobiology. University ofLeeds, Leeds,
United Kingdom
Objectives: To determine the relative frequency of species of coaguJase-
negative staphylococci (CONS) other than Staphylococcus saprophyticus in the
aetiology of acute lower urinary tract infection (UTI).
Methods: One hundred isolates, presumptively identified as CONS, were
collected from mid-stream specimens ofurine. Each isolate was judged to be
the cause of infection if there was (i) a clinical history suggestive of UTI (ii)
significant pyutia on microscopy (> 50 white cellsfhigh power field) (iii) a
pure growth (> 105 colony forming units/ml) on culture. Isolates were
identified to species level using the API Staph32 system.
Results: 72% ofspecimens were from women and 28% from men. 68% of
specimens originated from primary care, 20% from in-patients and 16%
from outpatient clinics. S. saprophytims was the causative bacterium in 60%
ofinfections; S. epidermidis (sensu stricto) in 21 %, S. haemolyticus in 7% and S.
sciur;, S. wartleri, and S. simula"s in 40/0 each.
Conclusion: Although CONS have long been recognised as a cause ofacute
lower UTI, the overwhelming majority ofisolates (= 95% in some reports)
have been deemed to be S. saprophytims. The present study shows that, in our
patient population at least, a range of CONS cause UTI. In addition, this
study may also have important implications for those laboratories that use
novobiocin resistance to presumptively identify CONS from urinary speci-
mens and novobiocin susceptibility as a criterion to discard isolates as non-
significant - because CONS other than S. saprophytims may, in fact,
frequently cause UTI.
IWeP1S! Primary pneumococcal peritonitis in a young woman
R. Bandettini!, R. Monacelli l , P. Parodi2, T. Coialbu2, F. Minervini2
'Clinical Pathology Dep"; 'Medicine Dept., "A. Gallino" Hospital; JLocal
Health Agency n.3, Genoa, Italy
Objectives: We report a case of primary pneumococcal peritonitis in a
previously healthy woman.
Clinical Case: A young woman of about 35 years of age was hospitalized
because of a persistent clinical picture characterized by fever (390 -4OCC),
vomiting, diarrhea and progressive generalized weakness in spite of an oral
therapy based on antipyretics and antibiotics (fluoroquinolones) started one
week before. Physical examination of the abdomen showed pain and
tenderness localized in the right quadrants. While chest radiography was
normal, abdominal ultrasonography detected small quantities of peritoneal
fluid and a distension of fluid-filled loops of small intestine. Laboratory
fmdings were characterized by a polymorphonuclear leukocitosis. Besides
three blood cultures were positive for a strain of Strep'ococcus pneumoniae
sensitive to quinolones. The adjustment of the antibiotic therapy (parenteral
administration) brought to a decrease of fever in less than 36 hours. Never-
theless a second abdominal ultrasonography and a computed tomography,
performed for the persistence ofabdominal tenderness and for a mild rigidiTy
ofthe abdominal wall, detected the presence ofmultiple abscesses within the
peritoneal cavity. Surgical treatment gave an excellent outcome and the
recovery of the patient.
Conduslons: Primary pneumonoccal peritonitis is very rare in adults with-
out predisposing conditions like cirrhosis, ascites, nephrotic syndrome,
autoimmune disease or immunodeficiency. Our patient did not belong to
anyone of these groups and she did not present a detectable port of entry
involving the lung, upper airways or genital tract. For this reason we can
consider it a rare case of primary pnemococcal peritonitis.
IWeP191 Unezolid in the treatment of streptococcol skin and
soft tissue infections: Combined results from three phase III
multinational dinical trials
M. Molinaril , R. Mangan01, M. Gough2, W. DeCian',Bassaris3
tGlobal Clinical Research Infectious Disease, P & U Milan, Italy; zLeeds
General Infirmary, Leeds, United Kingdom; JUniversity Hospital ofPatra,
Patras, Greece
Background: Linezolid is the first in a new class of antibiotics, the oxazo-
Iidinones, developed for the treatment of skin and soft tissue (SST) infec-
tions. Preliminary studies showed linezolid to be effective against both
sensitive and resistant gram-positive organisms. Three studies evaluated SST
infections; 2 studies compared LZD with clarithromycin for uncomplicated
SST infections; t .tudy compared LZD with oxacillin followed by diclox-
acillin for complicated SST infections. Patients were treated 7-28 days with
follow-up (FU) 7-21 day. after treatment completion. Results are presented
for patients with a SST infection due to Streptococcus pyogenes, and S.
agalactiae..
Results: 1904 patients (ITT) were treated in these 3 studies (948 LZD
recipients, 956 comparator recipients). Mean duration of therapy was
comparable between treatment groups in each study (range 11.0-14.3
days). Of the LZD recipients, 548 received 400 mg BID and 400 received
600 mg BID. The clinical cure at FU for microbiologically evaluable (ME)
patients with S. pyogenes isolated was 85% (34/40) for LZD and 88% (44/
50) for comparator (COM) recipients. The clinical cure for patients with S
agalactiae isolated was 100% (17/17) for LZD and 72.7% (8/11) for COM
recipients. The microbiological outcome at FU for ME patients with isolated
S pyogeness was 85% (34/40) for LZD and 86.2% (44/51) for COM
recipients. The microbioligical success rate for S agalactiae was 100% (17/
17) for LZD and 72.7% (8/11) for COM recipients.
Condusion: Linezolid is an effective new therapy for the treatment of
complicated and uncomplicated skin and soft tissue infections.
IWeP201 Unezolid in the treatment of staphylococcal skin and
soft tissue infections: Combined results from three phase III
multinational dinical trials
S. Duvall,]. Bru.s, W. Todd, B. Hafkin
Antibacterial Devrlopment, Pharmacia & Upjohn, Kalamazoo, MI, United
States
Background: Linezolid is the first in a new class of antibiotics, the oxazo-
lidinones, developed for the treatment of skin and soft tissue (SST) infec-
tions. Preliminary studies showed linezolid to be effective against both
sensitive and resistant gram-positive organisms. Three studies evaluated SST
infections; 2 studies compared LZD with clarithromycin for uncomplicated
SST infections; I study compared LZD with oxacillin followed by diclox-
acillin for complicated SST infections. Patients were treated 7-28 days with
follow-up (FU) 7-21 days after treatment completion. Results are presented
for patients with a SST infection due to Staphylococcus aureus,
Results: 1904 patients (ITT) were treated in these 3 studies (948 LZD
recipients, 956 comparator recipients). Mean duration of therapy was
comparable between treatment groups in each study (range 11.0-14.3
day.). Of the LZD recipients, 548 received 400 mg BID and 400 received
600 mg BID. The clinical cure at FU for microbiologically evaluable (ME)
patients with S aureus isolated was 90.1 % (201/223) for LZD and 88% ('229/
260) comparator (COM) recipients; cure rate for high-dose recipients was
89.2% (83/93) for LZD and 85.4% (88/103) for COM. The microbiological
success rate at FU for ME patients with isolated S aureus was 91 % (203/223)
for LZD and 85.9% (227/264) for COM; 89.2% (83/93) LZD and 84.5%
(87/103) for COM high dose recipients.
Condusion: Linezolid is an effective new therapy for the treatment of
complicated and uncomplicated skin and soft tissue infections.
IWeP21I Unezolid in the treatment of surgical wound
infectIons: Combined results from four phase III multinational
dlnical trials
]. Bruss, S. Duvall, W. Todd, B. Ha/kin
Antibacterial Development, Pharmacia & Upjohn, Inc, Kalamazoo, MI. United
States
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Background: Linezolid is the first oxazolidinone to be developed for the
treatment of skin and soft tissue infections (SST). Preliminary studies have
shown Iinezolid (LZD) to be effective against both sensitive and resistant
gram-positive bacteria.
Methods: Data from four studies evaluating patients with SST infections is
presented; 2 studies compared LZD to c1arithromycin for uncomplicated
SST; I study compared LZD to oxacillin followed by dicloxacillin for
complicated SST; 1 study compared LZD to vancomycin for infections due
to methicillin resistant Staphylococcus spp. Patients were treated 7-28 days
with follow-up (FU) 12-21 days after treatment completion. Results are
presented for patients diagnosed with an infected wound or infected surgical
incision.
Results: 2364 patients (ITT) were treated in these 4 studies (1188 LZD
recipients, 1176 comparator recipients). Mean duration of therapy was
comparable between treatment groups in each study and ranged from
11.0 to 14.3 days. The most common pathogens were Staphylococcus
aureus, Streptococcus pyogenes, and Streptococcus agalactiae. In clinically
evaluable (CE) patients, a diagnosis of infected wound or infected surgical
incision was made in 125 LZD treated patients and in 113 comparator-
treated patients. CE LZD recipients with a diagnosis of infected wound or
infected surgical incision had a cure rate of 82.4% (103/125) compared to
77.9% (88/113) for comparator recipients. For patients with an isolated
baseline pathogen the microbiologic success rate for LZD was 84.9% (73/86)
compared to 77.3% (68/88) for comparator recipients.
Conclusion: Linezolid is an effective new therapy for treating surgical
wound infections.
IWeP22ISubpopulational composition of blood lymphocytes
of diphtheria infected children
E. A. Guhshchina
State Academy ofPediatrics, St. Petersburg, Russian Federatioll
Objectives: To characterize of the subpopulational composition of lym-
phocytes in peripheral blood of children infected by the local form of
diphtheria and of bacterial carriers; as well to estimate the efficiency of
medicinal preparations.
Methods: For the determination of the subpopulational structure of lym-
phocytes (CD2, CD4, CD8, CD72, NK) the method of complement-
dependent cytotoxicity with monoclonal antibodies "Coulter Clone"
(USA) has been used.
Results: A group of35 kids of7-14 years old was under the experiment. Of
the total number of children, 15 healthy kids were constituting the control
group; 8 - infected by the local form of diphtheria: t2 - transient bacterial
carriers. A decreasing of the main parameters ofCD4, CD3, CD8 as 36%,
18%, and 15% respectively was established for children with local form of
diphtheria during the acute period (the first week ofdisease). After treatment
by means of antibiotics (penicillin, erythromycin etc.) and of immunity
modulating preparation ("Codivac") conducted during the period of con-
valescenting, the respective parameters for CD3 (54.4%) and CD8 (21.4%)
achieved the normal values. As for CD4 (24.8%), and CD72 (13.2%), the
tendencies towards normalization of the former, and some increasing of the
latter were recorded. Less pronounced changes in the immune system were
observed in the case of transient bacterial carriers. It was stated, that the
maximum greatest effect of treatment was achieved by means ofearly using
the "Codivac".
Conclusion: The data observed indicate the significant change in immune
system of diphtheria infected children and prove the early ordering of
complex treatment.
[WeP23I Brucefla strains isolated from humans in Greece
(1970-1999)
A. Kansouzidou, S. Mitka, T. Xipteridou, E. Poumbrou, A.
Papadopoulou, V. D. Daniilidis
Laboratory ofBacteriology, Infectious Diseases Hospital, Thessaloniki,
Macedonia, Greece
Brucellosis, even today, remains an important public health problem in
many countries, especially in the Mediterranean ones. In our country,
brucellosis cases were gradually reduced over the years, but during the last
five years a new resurgence is observed. In this study, the results oftyping of
572 Brucella spp strains isolated from humans all over Greece during the last
30 years and typed in our Laboratory, are reported. For Brucellla typing the
classic biological characters, the lysis by Tbilisi phage and the agglutination
reactions with absorbed monospecific A and M dantisera were used. Four-
teen strains were found to be in the rough phage and they could not be typed.
Ofthe remaini1lj558 strains only one (0.2%) was lysed by Tb phage (both in
R TD and in to XRTD) and in combination with the other properties this
strain was characterised as B. abortus biotype 1. All the other strains (557
strains) were B. melitensis, and specifically 14 strains (2.5%) were biotype I,
502 strains (90.0%) were biotype 2 and 41 strains (7.3%) were biotype 3. It is
concluded, that from humans in Greece almost exclusively B. melitensis
strains are isolated and in a proportion of 90.0% these strains belong to
biotype 2.
IWeP24IChildhood brucellossis in our region
E. Dimitrovska l , V. Mitrevska2, I. Kondova3, R. Dimitrovskil, D.
Balalovski I, DZ. Ristevska1
1Department of Infectious Diseases; 2Department ofPediatric Diseases, M.e.
Birola; ·'Clinic of Infectious Diseases, University Scopje, FYROM
The first patient with Brucellosis in Macedonia was diagnosed in 1980 y.
Since than Brucellossis in Macedonia has been present in Endo-epidemic
form among the cattle and people.
Objectives: To describe the epidemiology, clinical features, serological
findings and outcome ofchildhood brucelossis in our town and surrounding
villages.
Methods: Retrospective chart review of patients younger than 14 years
with brucellossis between 1980-1999 y.
Results: 49 children from 3 to 14 y. had brucellossis. 19 patients were from
Bitola and the other 30 were living in surrounding villages. Fewer (100%),
sweating (85%) arthralgias (64.9%) were the commonest symptoms. With
liver damage were 39.4% of patients, with Iimphadenopaties 30.2%. with
osteoanicular involvement 28.3%, with orchiepydidymitis 4.5%. There
was one child with brucellar meningitis. Diagnosis was confirmed with
serological findings (RoseBengal, Wright, Coombs. R VK Brucellae,
ELISA). Duration of treatment was between 30 to 42 days. 31 children
was treated with Streptomycin and Cotrimoxasol, 12 with Rifampicyn and
Doxicycline, and 6 with Streptomicyn. Rifampicyn and CotrimoxasoL The
overall relapse rate was 6.3%.
Conclusions: Brucellosis remains significant health problem among the
children in our region. We think that developing educational information
to country people and increase the epidemiological surveillance in endemic
communities with laboratory screenings tests will be more effective mea-
sures to take in terms of public health.
rvv-eP25] Surfactant peroxldation in GIS pneumonia
R. K. L. Bouhafsl , P. Rauprich2, E. Herting2, A. Schroder2, B.
Robertson3, C. Jarstrand l
tDepartment of Immunology, Microbiology alld Pathology, Karolinska Institute,
Stockholm, Sweden; 2Department ofPediatricsGermany; JDepartment of
Woman and Child Health, Karolinska Institute, Stockholm, Sweden
Objectives: In the newborn child group B streptococci (GBS) often cause
pneumonia with neutrophilic granulocytes (PMN) migrating into the lungs.
As surfactant therapy might be needed in such patients we tested the
interactions between GBS or GBS stimulated PMN and a modified natural
porcine surfactant preparation (Curosurf).
Methods: We studied the oxidative metabolism ofdifferent GBS strains and
of human PMN activated by GBS in vitro using the nitroblue tetrazolium
(NBT) test. The effect of reactive oxygen species (ROS) released from the
activated PMN or live bacteria on surfactant was estimated as the lipid
peroxidation (LPO). Vitamin E was used to counteract the LPO. The
inhibiting effect of surfactant on the growth of GBS was recorded and
related to the LPO. Finally, the effect of LPO caused by GBS stimulated
PMN on surfactant activity was evaluated by measuring surface tension in a
pulsating bubble surfactometer.
Results: Curosurf decreased the superoxide production by both live GBS
and GBS stimulated PMN. Surfactant was peroxidized by ROS from both
GBS and GBS-srimulated PMN in .. time dependent manner. Vitamin E,
however, could reduce the peroxidation level of surfactant significantly in
both cases. In experiments with live bacteria surfactant peroxidation was
peralleled by a decrease in bacterial number. Finally, the biophysical activity
of Curosurf was affected by GBS-stimulated PMN as an increase in
minimum surface tension was noticed.
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CondllSion: As Curosurf undergoes LPO by ROS. surfactant preparations
supplemented with vitamin E or other antioxidant might be useful for
treatment of bacterial pneumonia.
IWeP26IGranada medium as a screening procedure to avoid
neonatal Infection by S. aga/actiae
I. Montesinosl .]. L. Trujill02.]. Medero~.M. Cuervosl • A. Torresl • A.
Sierra I
1S. Microbiologia; 2S. Obstetricia y Ginecolog{a, Hospital Univmitario de
Canarias, La Laguna, Canarias. Spain
Objectives: To determin if materno fetal transmision of S. agalactiae.
Decerases in term pregnancies that undergo screening procedure. (Granada
medium) Vs those without it.
Method: We recolected a vaginal and rectal transcult. boht samples in the
same lUbe. in all term pregnancies between January and Dicember 1999. in
their first visit at the hospital on the 40th week of gestation.
We incubated the tubes at 37° C for 48 hours.
Positive results were identified due to thc produccion of an orange
pigment. These women Underwent intrapartum antibiotic profilaxis.
Results: A total of25% deliverys took Place at the Universitary Hospital of
Canaries. in 1999. 1006 pregnancies (36%) undcrwent screening with
grananda medium out ofwich 125 (12%) were positive. In the controlled
population 2 cases ofneonatal bacteriemia were detected. One ofthem had a
positive test but gave birth before 24 hours had past since the recolection of
the sample. The other one was negative. In both cases bacteriemia was
produced by non-hemolitic Streptococcus.
In the other group (wibtout screenig control) there were 8 bacterihemia
cases (0.5%) and one neonatal sepsis.
There were 0.3% less bacteriemias in the controlled group (screening test
with granada medium) then in the non controlled one.
Conclussion: The Granada medium appears to be a good screenig test to
reduce Vertical transmission by S. Agalactiae.
jWeP27! Function of antibodies against Fbe In the adherence
between S. epidermidis and fibrinogen-coated catheters
L. Pei. J. -I. Flock
Div. ofClinical Bactrriology, Huddinge Hospital, Huddinge, Sweden
Objectives: To investigate the function of the antibodies raised aganist Fbe
(a fibrinogen binding protein from S. epidermidi<) in the adherence between
S. epidermidis and fibrinogen - coated catheters
Methods:
• purification by affinity chromatography of recombinant Fbe
• antibodies purification from rat's sera raised against Fbe and from
control sera
• blocking assay between S. epidermidis and Fg-coated catheters by using
antibodies against Fbe and control antibodies
Results: • in vitro. S. epidermidis can bind to fibrinogen-coated catheters in
a close-dependent manner. which suggests that Fbe. the main Fg binding
protein from S. epidermidis. may playa role in bacterial associated catheter
infection in vivo
• antibodies against Fbe can block the adhesion of S. epidermidis to Fg-
coated catheters approximately to 90%. while the control antibodies can
only block to 25%.
Condusions: Catheter infections with S. epidermidis has become a common
reason for the failure of implantation. Bacterial adherence to extracellulose
matrix proteins is considered to initate the colonization of bacteia to the
implanted biomaterial. In our present study. we have shown that antibodies
against one ofthe adhesins - Fbe from the surface ofS. epidermidis can block
the adherence of the bacteria to Fg-coated catheters effectively. It suggests
that passive immunization by using antibodies against the bacterial surface
components may reduce the infections caused by the colonization of the
bacteria in the implantations.
IWeP2S1 Erythromydn-resistance of group B stteptococd
Isolated in Greece
A. Voyatzi. S. Mela. D. Apostolou. V. Petrocheilou-Paschou
Dept. ofClinical Microbiology cif"Alexandra" Maternity Hospital, Athens,
Greece
Objectives: The aim of this study was to determine the incidence of
erythromycin-resistant group B streptococci (GBS).
Methods: During a seven month period 240 GBS isolates were obtained
from vaginal smears of 2932 non pregnant and 534 pregnant women, who
were examined in our hospital. Isolates ofGBS were identified by biochem-
ical features (Api-Strep.Biomerieux) and serological test (Streptococcal
Grouping Kit. Oxoid). Erythromycin resistance (ER) was determined by
discs diffusion method (Kirby-Bauer). MICs were determined by the E test.
Susceptibility of the following antibiotics was determined: penicillin G (P),
oxacillin (0). ampicillin. erythromycin (E). clindamycin (C). gentamicin
(;?:500 mg/L) and vancomycin. ER phenotypes were distinguished by a
double disc test. (E 15 /log. C 2 /log).
Results: Non pregnant women were found to be colonized by GBS at a
frequency of5.3% (157/2932). while pregnant ones at 15.5% (83/534). Forty
four ofER isolates (18%) were detected of240 GBS isolates and 27 of them
were also resistant to c1indamycin (11 %). Three different ER phenotypes
were classified: i) Constitutive resistance was found in 27/44 ofGBS isolates
(11 %), (E MICs 4-256 mgfL - C %-256 mg/L). ii) Inducible MLS
phenotype was found in 4.1% (10/44). (E MICs 1-4 mg/L - C < 0.25
mg/L) and iii) The M resistance phenotype was in 3% (7/44) (E MICs > 8
mg/L - C ~ 0.094-0.25 mg/L). Only one GBS isolate showed P MIC 2 mg/L
and resistance to 0 (8 mg/L), E (4 mg/L) and C (% mg/L).
Conclusions: Those data showed that: I. The majority of GBS isolates still
remain susceptible to penicillin. 2. Erythromycin - resistance ofGBS isolates
from vaginal swabs is increasing in our country. Continued surveillance of
GBS susceptibility to antibiotics is needed.
IWeP29ICost of fusidic add resistance for Staphylococcus
aureus
D. Hughes. I. Nagaev.]. Bjorkman1•2• D. Andersson2
tDepartment ofCell and Molecular Biology, BMC, Uppsala; 2Swedish Institute
for Infectious Disease Control, Solna, Sweden
Objectives: To determine the nature and associated costs of fusidic acid
resistant mutations in Staphylococcus aureus.
Methods: Fusidic acid resistant mutants were selected in vitro in S. aureus
FDA486. FusR isolates were competed against wild-type S. aureus in a rat
abscess model to determine the cost of antibiotic resistance. FusR mutants
were also cycled in the rat model to select fitness/virulence-compensating
mutations.
Results: The in vitro-selected FusR mutants fall into two clear groups. One
group. have single amino acid substitutions in jus the gene for translation
factor EF-G. These mutants have MIC values across the entire range and
include both fast and slow growers. The second group does not have
mutations inJus, their MIC values are uniform at 5 /log/ml and all are slow
growing. Within a group ofFusR clinical isolates examined approximately
one third have mutations inJus associated with a wide range ofMIC values.
The mutation inJus are in structural domains I and III ofEF-G. in both the in
vitro-selected and clinical FusR isolates. In competition experiments in the rat
the FusR mutants generally fee lose, indicating a significant cost related to
this antibiotic resistance. In cycling experiments in the rat. virulence-
compensating mutations were selected. Most are revertants to Fusidic acid
sensitivity.
Conclusions: Fusidic acid resistance is rare in clinical isolates ofS. aureus. The
cost ofresistance to the bacteria. and the difficulty ofrestoring fitness without
losing resistance may be significant factors in hindering the spread ofFusidic
acid resistance. A large number of resistant isolates are not altered in EF-G.
IWeP30IGroup A streptococcal (GAS) infections in Norway up
to 31/12199
E. A. H000iby. V. Hasseltvedt
The Norwegian Strtptolo«al Disease Working Group, Nat'/Inst. Publ.
Health, Oslo, Norway
Background: Norway has together with many other countries experienced
a resurgence of invasive GAS disease since the 1980..
Methods: Data from The Norwegian Notification System for infectious
Diseases and The Department of Bacteriology have been combined to have
an overlook of the GAS epidemiological situation.
Results: In Norway (population 4.3 million). the epidemiology ofinvasive
GAS disease changed commencing around 1985. Markedly increased
incidences were nOled 1985 and 1987~88. The 1988 outbreak proved
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IWeP32IPneumococcal bacteremia in pediatrics
Conclusions: There is need to continously monitor the Norwegian GAS
situation and be aware of this most serious and increasing health problem.
IWeP31I Comparison of 2 strategies for the detection of s.
agalaetiae (GIS) carrlership In pregnant women
IWeP33IFrequency of MRSA isolation in hospitals and the
community In Benghazi-Ubya
I. A. A. Taher, S. EI-Gadi, N. M. Shembesh l , R. S. Tobgi
Department of Microbiology, AL-Arab Medical University; I AL-Fateh
Children's Hospital, Benghazi, Libya
Objectives: To determine the incidence of MRSA and antibiotic suscept-
ibility in the main children's hospital and within the community of
Benghazi.
Methods: Standard microbiological procedures were carried out to isolate
S. aureus from patients, healthcare workers and general population. The
antibiotic sensitivity ofthe isolates was determined by Bauer-Kirby method.
Results: In general 129 S. aureus were isolated from the hospital and 109
from the community. Of these 35 (27%) and 21 (19%) were MRSA
respectively. The spread of MRSA in the hospital was high in the intensive
care (45%); dialysis (36%); and neonatal units (31 %) respectively. MRSA
showed significantly high resistance towards fusidic acid (80%); kanamycin
(27%); augmentin (14%) and chloramphenicol (9%).
Conclusions: A great care must be taken in order to prevent the spread of
MRSA between patients and/or health care workers. Further molecular
typing studies are needed.
P:418 - Mydobaderial infections
IMoP136! TUberculosis prevention and treatment program for
homeless in St.-Petersburg
L. Goulielmil • V. Galkin l , N. Skrynnilc? E. Savinel
I Research Institute ofPhthysiopulmonology; 2District TB Dispenser N12, St.-
Petersburg. Russian Federation
Objectives: To evaluate the effectiveness of TB program for homeless in
Admiralteysky District of St.-Petersburg.
Methods: 719 persons (males) were examined before implementation ofthe
program and additionally 1333 after it has been developed. General
examination, and direct sputum microscopy, as well as X-ray examination
were conducted. WHO recommended DOTS schedules and criteria have
been used. Access to treatment was unrestricted and have been additionally
stimulated by free of charge meals distribution in special canteen.
Results: During the year ofthe program existence there have been detected
twice more cases of tuberculosis as compared to the period of 3 previous
years. The destruction frequency in patients with active pulmonary TB
decreased from 59% to 34%. Initial phase of the treatment was completed in
43.8%.
Conclusions: The program allows to reduce the number of unknown
sources of infection. to improve the quality of TB control and provides
cost-effective out-patient treatment.
otitis (5), primary bacteremia (2), skin (1) and meningitis (I). Total
pneumococcal isolations in these years have not suffered great variations,
however, isolations in children represented: 4.65% in 1994. 8.69% in 1995,
13.72% in 1996,10.34% in 1997,14.89% in 1998 and 35% in 1999. 16 ofthe
isolations were susceptible to all antibiotics and 6 microorganisms were
resistant to penicillin and erythromycin. None of the patients died.
Conclusions: The frequency of pneumococcal isolations in children had
been increasing and, above all. in the last year. Because of the morbidity of
this infection and the appearance ofresistances in S. pneumoniae is important
to keep under surveillance this increase in order to start the appropriate
therapy.
Objectives: To improve efficacy oftreatment for drug-resistant pulmonary
TB.
Methods: Microscopy and microbiology sputum studies including drug
resistance determination by direct and indirect methods and using
BACTEC-460.
Results: 106 patients with drug-resistant pulmonary TB were studied. Out
of them 17% had monoresistance to isoniazid or streptomycin; 15.1 % had
IMoP1371 Ways to improve ecacy of drug-resistant
pulmonary TB treatment
V. Mishin
Central TB Research Institute, Moscow, Russian Federation
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Specimen: Blood-agar Vaginal Anal
Technique: (+CAMP) Granada Granada
132 Neg Neg Neg
1 Neg Pos Pos
I Neg Pos Neg
3 Pos Pos Neg
11 Neg Neg Pos
17 Pos Pos Pos
Posit.: 33/165 20/165 22/165 29/165
(20%) (12%) (13.5%) (17.5%)
G. Claeys, G. Verschraegen, C. Labit
Laboratory for Bacteriology and Virology, University Hospital, Ghent, Belgium
Aim: better and faster detection of GBS carriers among pregnant women
Study: we compared our classical technique of vaginal cultures (blood-
agar, identification ofGBS with CAMP-test) with a new approach: culture
ofa vaginal and an anal specimen on Granada agar. We compared the results
ofvaginal and anal samples from 165 pregnant women (IUO trim.)
Results: More difficulties in interpretation of test results with CAMP than
with Granada agar (no false positive or false negative reactions)
Yield:
almost monoclonal (Tt), but the epidemic unexpectedly rapidly waned. In
the following years, the number of cases remained very low. From early
1993 we again have suffered a still ongoing outbreak, with even higher
incidences than in the 1980s. This is particularly true for 1994 and 1998/99.
We have recognized clinical syndromes very seldom encountered in the
preceding decades; such as GAS pneumonia, necrotizing fasciitis, puerperal
septicaemia, meningitis and, ofcourse, STSS. In 1999 the incidence was 264
cases (38 deaths) compared to 267 cases and 39 deaths in 1998. Ofthe systemic
cases in 1998 T-l, OF- dominates with around 40%, while about 11 % are
83264 alone or together with other rypes. Eight percent ofthe cases were T3.
As shown in the table below there are more young women than men
affected. This is due to an increasing problem with infections originating
from the female urogenital tract. In effect apporximately 20% or more of
cases among women are in this category.
Serious invasive GAS disease in Norway 1999 by sex and age group
Condusions: Increase of detected GBS carriers: from 12% (classical
approach) to 20% (vaginal + anal specimen cultured on Granada medium)
Decreased detection time: results obtained in 18 hours
Ease ofidentification: granada medium better than CAMP-test
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Objectives: S. pneumoniae is the most common cause of invasive bacterial
infection in children with an annual incidence between 45 to 145 cases/
100000 population of children > 2 years old.
Methods: Children younger than 6 years old with blood cultures positive to
S. pneumoniae, were prospectively studied until the end of their episode by
infection control personnel in the Hospital of Basurto from 1994 to 1999.
The Hospital of Basurto is a 800 bed primary and tertiary care, teaching
hospital that provides care in the urban area of Bilbao (Spain).
Results: There have been 44 children with bacteremia 30 (68.18%) ofwhich
were males. Most of the children (75%) were younger than 2 years old.
Children had no underlying illness apart from otitis amigdalitis (1), osteo-
genic sarcoma (1) and asthma (1). Sources of bacteremia: respiratory (35),
